BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27919945)

  • 21. 15-lipoxygenase-1/15-hydroxyeicosatetraenoic acid promotes hepatocellular cancer cells growth through protein kinase B and heat shock protein 90 complex activation.
    Ma J; Zhang L; Zhang J; Liu M; Wei L; Shen T; Ma C; Wang Y; Chen Y; Zhu D
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1031-41. PubMed ID: 23474367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UDP-galactose pyrophosphorylase in mice with galactose-1-phosphate uridyltransferase deficiency.
    Leslie N; Yager C; Reynolds R; Segal S
    Mol Genet Metab; 2005 May; 85(1):21-7. PubMed ID: 15862277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactose metabolism in isolated perfused suckling-rat liver.
    Berman W; Rogers S; Bautista J; Segal S
    Am J Physiol; 1979 Jun; 236(6):E633-7. PubMed ID: 443419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GALT deficiency causes UDP-hexose deficit in human galactosemic cells.
    Lai K; Langley SD; Khwaja FW; Schmitt EW; Elsas LJ
    Glycobiology; 2003 Apr; 13(4):285-94. PubMed ID: 12626383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactose toxicity in animals.
    Lai K; Elsas LJ; Wierenga KJ
    IUBMB Life; 2009 Nov; 61(11):1063-74. PubMed ID: 19859980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Culture of galactosaemic fibroblasts in the presence of galactose: effect of inosine.
    Pourci ML; Mangeot M; Soni T; Lemonnier A
    J Inherit Metab Dis; 1990; 13(6):819-28. PubMed ID: 2079832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.
    Slepak TI; Tang M; Slepak VZ; Lai K
    Mol Genet Metab; 2007; 92(1-2):78-87. PubMed ID: 17643331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose.
    Segal S; Wehrli S; Yager C; Reynolds R
    Mol Genet Metab; 2006 Feb; 87(2):92-101. PubMed ID: 16260165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA.
    Shi Y; Wang SY; Yao M; Sai WL; Wu W; Yang JL; Cai Y; Zheng WJ; Yao DF
    World J Gastroenterol; 2015 Dec; 21(45):12814-21. PubMed ID: 26668505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of hepatic galactose-metabolizing enzymes in the pregnant rat and fetus.
    Rogers SR; Bovee BW; Saunders SL; Segal S
    Pediatr Res; 1989 Feb; 25(2):161-6. PubMed ID: 2537489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Galactosemia].
    Owada M
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):647-51. PubMed ID: 3270877
    [No Abstract]   [Full Text] [Related]  

  • 37. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma.
    Li WF; Ou Q; Dai H; Liu CA
    Int J Mol Sci; 2015 Aug; 16(8):19419-32. PubMed ID: 26287185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Homogeneous Polysaccharide from Fructus Schisandra chinensis (Turz.) Baill Induces Mitochondrial Apoptosis through the Hsp90/AKT Signalling Pathway in HepG2 Cells.
    Chen Y; Shi S; Wang H; Li N; Su J; Chou G; Wang S
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and analysis of galactose metabolic pathway variants of a mouse liver cell line.
    Zaret KS; Stevens KA
    Mol Cell Biol; 1990 Sep; 10(9):4582-9. PubMed ID: 2167434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.